EYE vs. WRBY, RXST, STAA, BLCO, ARDX, VCYT, INMD, ADMA, EWTX, and DAWN
Should you be buying National Vision stock or one of its competitors? The main competitors of National Vision include Warby Parker (WRBY), RxSight (RXST), STAAR Surgical (STAA), Bausch + Lomb (BLCO), Ardelyx (ARDX), Veracyte (VCYT), InMode (INMD), ADMA Biologics (ADMA), Edgewise Therapeutics (EWTX), and Day One Biopharmaceuticals (DAWN). These companies are all part of the "medical" sector.
Warby Parker (NYSE:WRBY) and National Vision (NASDAQ:EYE) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, dividends, community ranking, risk, profitability, valuation and earnings.
Warby Parker has a beta of 1.63, meaning that its share price is 63% more volatile than the S&P 500. Comparatively, National Vision has a beta of 1.39, meaning that its share price is 39% more volatile than the S&P 500.
93.2% of Warby Parker shares are held by institutional investors. 26.9% of Warby Parker shares are held by insiders. Comparatively, 2.1% of National Vision shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Warby Parker has higher earnings, but lower revenue than National Vision. Warby Parker is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.
National Vision received 230 more outperform votes than Warby Parker when rated by MarketBeat users. Likewise, 66.06% of users gave National Vision an outperform vote while only 32.86% of users gave Warby Parker an outperform vote.
Warby Parker currently has a consensus price target of $16.29, suggesting a potential upside of 27.73%. National Vision has a consensus price target of $23.86, suggesting a potential upside of 33.50%. Given Warby Parker's higher possible upside, analysts clearly believe National Vision is more favorable than Warby Parker.
In the previous week, National Vision had 4 more articles in the media than Warby Parker. MarketBeat recorded 7 mentions for National Vision and 3 mentions for Warby Parker. Warby Parker's average media sentiment score of 0.50 beat National Vision's score of -0.19 indicating that National Vision is being referred to more favorably in the news media.
National Vision has a net margin of -3.10% compared to National Vision's net margin of -9.44%. Warby Parker's return on equity of 3.69% beat National Vision's return on equity.
Summary
National Vision beats Warby Parker on 10 of the 18 factors compared between the two stocks.
Get National Vision News Delivered to You Automatically
Sign up to receive the latest news and ratings for EYE and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding EYE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
National Vision Competitors List
Related Companies and Tools
